Try the Demo today!
| SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
|---|---|---|---|---|---|---|---|---|
| 15-Feb-24 5:35 PM View:  | Neurocrine Biosciences Inc. (NBIX) | 13-Feb-24 | Private Sale (Planned) | 796 | $133.04 | $105,902.00 | (4%) 18.77K to 17.98K | |
| 08-Feb-24 7:35 PM View: | Neurocrine Biosciences Inc. (NBIX) | 08-Feb-24 | Sale (Planned) | 1,329 | $135.44 | $179,995.00 | (7%) 18.59K to 17.26K | |
| 08-Feb-24 7:35 PM View: | Neurocrine Biosciences Inc. (NBIX) | 06-Feb-24 | Private Sale (Planned) | 1,215 | $142.07 | $172,617.00 | (7%) 18.48K to 17.26K | |
| 02-Feb-24 7:11 PM View: | Neurocrine Biosciences Inc. (NBIX) | 31-Jan-24 | Private Sale (Planned) | 1,740 | $141.29 | $245,842.00 | (9%) 19.0K to 17.26K | |
| 27-Dec-23 4:08 PM View: | Neurocrine Biosciences Inc. (NBIX) | 22-Dec-23 | Option Exercise | 24,000 | $73.04 | $1,752,900.00 | 139% 17.26K to 41.26K | 5% |
| 27-Dec-23 4:08 PM View: | Neurocrine Biosciences Inc. (NBIX) | 22-Dec-23 | Planned Private Option Sale | 24,000 | $128.66 | $3,087,810.00 | (58%) 41.26K to 17.26K | |
| 06-Sep-23 4:22 PM View: | Neurocrine Biosciences Inc. (NBIX) | 01-Sep-23 | Private Sale (Planned) | 824 | $110.93 | $91,406.30 | (5%) 18.09K to 17.26K | |
| 23-Aug-23 8:03 PM View: | Neurocrine Biosciences Inc. (NBIX) | 21-Aug-23 | Private Sale (Planned) | 2,132 | $107.41 | $228,991.00 | (11%) 20.22K to 18.09K | |
| 03-May-23 5:28 PM View: | Neurocrine Biosciences Inc. (NBIX) | 01-May-23 | Private Sale (Planned) | 11,397 | $103.89 | $1,184,050.00 | (41%) 27.57K to 16.17K | |
| 27-Apr-23 4:37 PM View: | Neurocrine Biosciences Inc. (NBIX) | 25-Apr-23 | Private Sale (Planned) | 100 | $103.82 | $10,382.00 | (< 1%) 27.66K to 27.56K | |
| 08-Feb-23 7:56 PM View: | Neurocrine Biosciences Inc. (NBIX) | 08-Feb-23 | Sale (Planned) | 1,328 | $103.83 | $137,883.00 | (5%) 28.75K to 27.42K | |
| 08-Feb-23 7:56 PM View: | Neurocrine Biosciences Inc. (NBIX) | 07-Feb-23 | Sale (Planned) | 14,536 | $102.49 | $1,489,780.00 | (35%) 41.96K to 27.42K | |
| 08-Feb-23 7:56 PM View: | Neurocrine Biosciences Inc. (NBIX) | 06-Feb-23 | Private Sale (Planned) | 1,215 | $104.90 | $127,459.00 | (7%) 17.14K to 15.93K | |
| 02-Feb-23 5:07 PM View: | Neurocrine Biosciences Inc. (NBIX) | 31-Jan-23 | Private Sale (Planned) | 916 | $108.48 | $99,367.70 | (5%) 16.84K to 15.93K | |
| 10-Nov-22 5:47 PM View: | Neurocrine Biosciences Inc. (NBIX) | 08-Nov-22 | Option Exercise | 5,592 | $81.05 | $453,232.00 | 37% 15.1K to 20.69K | (6%) |
| 10-Nov-22 5:47 PM View: | Neurocrine Biosciences Inc. (NBIX) | 08-Nov-22 | Planned Private Option Sale | 5,592 | $124.99 | $698,949.00 | (27%) 20.69K to 15.1K | |
| 04-Nov-22 5:02 PM View: | Neurocrine Biosciences Inc. (NBIX) | 03-Nov-22 | Option Exercise | 7,264 | $81.05 | $588,747.00 | 48% 15.1K to 22.37K | |
| 04-Nov-22 5:02 PM View: | Neurocrine Biosciences Inc. (NBIX) | 03-Nov-22 | Planned Option Sale | 7,264 | $125.00 | $908,034.00 | (32%) 22.37K to 15.1K | |
| 04-Nov-22 5:02 PM View: | Neurocrine Biosciences Inc. (NBIX) | 02-Nov-22 | Option Exercise | 1,144 | $81.05 | $92,721.20 | 8% 15.1K to 16.25K | (6%) |
| 04-Nov-22 5:02 PM View: | Neurocrine Biosciences Inc. (NBIX) | 02-Nov-22 | Planned Private Option Sale | 1,144 | $124.97 | $142,963.00 | (7%) 16.25K to 15.1K | |
| 09-Aug-22 6:54 PM View: | Neurocrine Biosciences Inc. (NBIX) | 05-Aug-22 | Private Sale (Planned) | 1,816 | $100.00 | $181,600.00 | (11%) 16.92K to 15.1K | |
| 29-Jun-22 4:26 PM View: | Neurocrine Biosciences Inc. (NBIX) | 27-Jun-22 | Private Sale (Planned) | 754 | $100.00 | $75,400.00 | (4%) 17.67K to 16.92K | |
| 09-Feb-22 6:55 PM View: | Neurocrine Biosciences Inc. (NBIX) | 08-Feb-22 | Sale (Planned) | 700 | $79.56 | $55,689.10 | (4%) 18.11K to 17.41K | |
| 09-Feb-22 6:55 PM View: | Neurocrine Biosciences Inc. (NBIX) | 07-Feb-22 | Private Sale (Planned) | 2,158 | $80.65 | $174,038.00 | (11%) 18.94K to 16.78K | |
| 06-Oct-21 4:37 PM View: | Neurocrine Biosciences Inc. (NBIX) | 04-Oct-21 | Market Sale (Planned) | 987 | $101.73 | $100,408.00 | (6%) 15.83K to 14.84K | 2% |
| 09-Feb-21 9:24 PM View: | Neurocrine Biosciences Inc. (NBIX) | 08-Feb-21 | Market Sale (Planned) | 1,338 | $116.73 | $156,190.00 | (9%) 15.07K to 13.74K | < 1% |
| 09-Feb-21 9:24 PM View: | Neurocrine Biosciences Inc. (NBIX) | 05-Feb-21 | Market Sale (Planned) | 605 | $113.86 | $68,886.20 | (5%) 12.73K to 12.13K | (2%) |
| 16-Nov-20 6:10 PM View: | Neurocrine Biosciences Inc. (NBIX) | 12-Nov-20 | Market Sale (Planned) | 2,257 | $90.73 | $204,778.00 | (16%) 13.84K to 11.58K | (27%) |
| 06-Oct-20 4:05 PM View: | Neurocrine Biosciences Inc. (NBIX) | 02-Oct-20 | Market Sale (Planned) | 987 | $95.26 | $94,021.60 | (9%) 10.54K to 9.55K | (21%) |
| 07-Aug-20 7:21 PM View: | Neurocrine Biosciences Inc. (NBIX) | 05-Aug-20 | Market Sale (Planned) | 2,257 | $118.91 | $268,383.00 | (21%) 10.92K to 8.66K | 3% |
| 28-Apr-20 8:38 PM View: | Neurocrine Biosciences Inc. (NBIX) | 24-Apr-20 | Market Sale (Planned) | 1,934 | $99.46 | $192,364.00 | (23%) 8.56K to 6.63K | (16%) |
| 11-Feb-20 7:10 PM View: | Neurocrine Biosciences Inc. (NBIX) | 07-Feb-20 | Market Sale (Planned) | 913 | $103.26 | $94,276.20 | (16%) 5.56K to 4.64K | (12%) |
| 07-Feb-20 6:38 PM View: | Neurocrine Biosciences Inc. (NBIX) | 05-Feb-20 | Market Sale (Planned) | 605 | $103.17 | $62,417.30 | (14%) 4.43K to 3.82K | (12%) |
| 04-Oct-19 6:15 PM View: | Neurocrine Biosciences Inc. (NBIX) | 02-Oct-19 | Market Sale (Planned) | 987 | $88.56 | $87,408.70 | (23%) 4.26K to 3.28K | (31%) |